University of Leicester
Browse

Incidence of gestational diabetes in pregnant women with a history of bariatric surgery using a service evaluation

Download (978.36 kB)
journal contribution
posted on 2025-09-24, 15:25 authored by B Jenner, D Jones, Laura KusinskiLaura Kusinski, C Patient, A Park, A Sarker, V Bansiya, EM Gurnell, Claire MeekClaire Meek
Background: Pregnant women with previous bariatric surgery are at increased risk of gestational diabetes mellitus (GDM) but many cannot safely tolerate the oral glucose tolerance test (OGTT). Consensus recommendations advise self-monitoring of blood glucose (SMBG) for GDM diagnosis, but diagnostic thresholds are unexplored in this population. Study objective: To assess the incidence of SMBG-defined GDM (fasting, 1-hr postprandial thresholds: 90, 140 mg/dL (5.3, 7.8 mmol/L)) after bariatric surgery, compared to the incidence of OGTT-defined GDM in women with risk factors for GDM but no history of bariatric surgery. Design and setting: Patients with a history of bariatric surgery (n=24) were included in a retrospective service evaluation based at a single tertiary referral centre in England, with results compared to a national study of women at high risk of GDM but without a history of bariatric surgery (n=1,308). Main outcome measures: The incidence of GDM diagnosed according to SMBG vs OGTT. Results: GDM incidence was 16/24 (66.7%; SMBG-defined) after bariatric surgery and 121/1,308 (9.3%; OGTT-defined) in the control group, with the highest incidence rates seen after gastric bypass (85.7%). In women with previous bariatric surgery, HbA1c showed no association with GDM diagnosis, the requirement for treatment or offspring birth weight. Conclusions: SMBG at standard thresholds is not able to reliably diagnose GDM after bariatric surgery and is likely to over-diagnose GDM, especially after gastric bypass, although small sample size limits generalisability of this study. Alternative diagnostic and prognostic markers are warranted for diagnosis of GDM after bariatric surgery.<p></p>

Funding

Chewing the fat: gestational weight gain, gestational diabetes and pregnancy outcomes, a multi-site, randomised, controlled interventional study

Diabetes UK

Find out more...

European Foundation for the Study of Diabetes - Novo Nordisk Foundation (NNF19SA058974).

NIHR Cambridge BRC

National Institute for Health Research

Find out more...

History

Author affiliation

College of Life Sciences Medical Sciences

Version

  • VoR (Version of Record)

Published in

Clinical Medicine

Volume

25

Issue

3

Pagination

100318

Publisher

Elsevier BV

issn

1470-2118

eissn

1473-4893

Copyright date

2025

Available date

2025-09-24

Spatial coverage

England

Language

en

Deposited by

Dr Laura Kusinski

Deposit date

2025-09-10